Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 100 of 1294 entries
View as:

A Study Following People With Haemophilia A and B, With or Without Inhibitors, When on Usual Treatment (Explorer™6)

Phase: N/A Priority: Normal
NCT ID: NCT03741881 Org: User:
Start: 12/18/18 End: 10/25/21 Due: 10/25/22

Bioequivalence of Two Somatropin Products (Norditropin® Versus Genotropin®) in Healthy Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01401244 Org: User:
Start: 07/14/11 End: 09/27/11 Due: 09/27/12

A Trial Investigating the Efficacy and Safety of Insulin Degludec/Insulin Aspart Once Daily Plus Insulin Aspart for the Remaining Meals Versus Insulin Detemir Once or Twice Daily Plus Meal Time Insulin Aspart in Children and Adolescents With Type 1 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT01835431 Org: User:
Start: 10/17/13 End: 11/07/14 Due: 11/07/15

Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin in Subjects With Type 2 Diabetes (SUSTAIN - CHINA MRCT)

Phase: N/A Priority: Normal
NCT ID: NCT03061214 Org: User:
Start: 08/28/17 End: 04/15/19 Due: 04/15/20

Safety and Efficacy of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart as Mealtime Insulin in Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00095082 Org: User:
Start: 09/30/04 End: 12/31/05 Due: 12/31/06

Observational Study on the Weight Effect of Insulin Detemir (Levemir®) in Type 2 Diabetics

Phase: N/A Priority: Normal
NCT ID: NCT00697450 Org: User:
Start: 07/31/08 End: 12/31/09 Due: 12/31/10

A Research Study, Looking at How Tresiba® Works in People With Type 2 Diabetes in Local Clinical Practice in China

Phase: N/A Priority: Normal
NCT ID: NCT04227431 Org: User:
Start: 01/17/20 End: 07/17/21 Due: 07/17/22

Investigating the Long-term Efficacy and Safety of Two Doses of NN-220 (Somatropin) in Short Stature Due to Noonan Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT01927861 Org: User:
Start: 08/19/13 End: 07/12/18 Due: 07/12/19

Comparison of NN1250 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01074268 Org: User:
Start: 02/28/10 End: 12/31/10 Due: 12/31/11

Efficacy and Safety of a Fixed or a Flexible Supplementary Insulin Therapy in Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00274274 Org: User:
Start: 09/30/05 End: 11/30/06 Due: 11/30/07

A Research Study to See How Well Different Doses of CagriSema Help People With Excess Body Weight Lose Weight

Phase: N/A Priority: Normal
NCT ID: NCT06388187 Org: User:
Start: 06/24/24 End: 04/21/26 Due: 04/21/27

Haemophilia Patients With Inhibitors Being Treated for Acute Joint Bleeds

Phase: N/A Priority: Normal
NCT ID: NCT00486278 Org: User:
Start: 06/30/07 End: 06/30/10 Due: 06/30/11

A Research Study to See How Well CagriSema Helps People With Type 2 Diabetes and Excess Body Weight Lose Weight

Phase: N/A Priority: Normal
NCT ID: NCT05394519 Org: User:
Start: 02/01/23 End: 02/03/25 Due: 02/03/26

A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor

Phase: N/A Priority: Normal
NCT ID: NCT06065540 Org: User:
Start: 09/27/23 End: 01/05/26 Due: 01/05/27

Safety, Efficacy, Tolerability and Pharmacokinetics of NNC 0070-0002-0182 in Overweight or Obese Male and Female Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00665665 Org: User:
Start: 11/30/07 End: 10/31/08 Due: 10/31/09

Efficacy and Safety of Inhaled Pre-prandial Human Insulin in Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00348712 Org: User:
Start: 10/30/06 End: 03/05/08 Due: 03/05/09

Study on How Fiasp® Can Influence Blood Sugar Levels of type1 Diabetic Patients in Their Daily Lives, With the Help of the Freestyle Libre® Device

Phase: N/A Priority: Normal
NCT ID: NCT03450863 Org: User:
Start: 03/22/18 End: 09/04/19 Due: 09/04/20

Efficacy and Safety of Semaglutide Versus Dulaglutide as add-on to Metformin in Subjects With Type 2 Diabetes.

Phase: N/A Priority: Normal
NCT ID: NCT02648204 Org: User:
Start: 01/06/16 End: 05/19/17 Due: 05/19/18

Observational Study of Safety of NovoMix® 30 Treatment for Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01486875 Org: User:
Start: 01/31/06 End: 01/31/08 Due: 01/31/09

Observational Registry of the Treatment of Glanzmann's Thrombasthenia

Phase: N/A Priority: Normal
NCT ID: NCT01476423 Org: User:
Start: 01/31/04 End: 10/31/11 Due: 10/31/12

A Cross-Sectional Survey to Evaluate Diabetes Management, Control, Complications, Psychosocial Aspects of Patients With Type 2 Diabetes in Bangladesh, Indonesia, Malaysia, Philippines, Sri Lanka and Vietnam

Phase: N/A Priority: Normal
NCT ID: NCT02066766 Org: User:
Start: 04/22/15 End: 08/31/15 Due: 08/31/16

A Trial to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NNC0215-0384 Administered to Subjects With Moderate to Severe Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01955603 Org: User:
Start: 09/30/13 End: 10/31/14 Due: 10/31/15

Effect of Renal Impairment on the Pharmacokinetics of NN9535

Phase: N/A Priority: Normal
NCT ID: NCT00833716 Org: User:
Start: 02/02/09 End: 07/26/10 Due: 07/26/11

A Study Investigating the Clinical Parameters Associated With the Use of Ryzodeg® (Insulin Degludec/Insulin Aspart) in a Real-world Adult Population With Type 2 Diabetes in South Korea

Phase: N/A Priority: Normal
NCT ID: NCT04656106 Org: User:
Start: 04/27/21 End: 07/01/21 Due: 07/01/22

A Study of All-Cause and Cardiovascular Mortality in Type 2 Diabetes Patients Using Basal Insulin Detemir and Glargine

Phase: N/A Priority: Normal
NCT ID: NCT03960814 Org: User:
Start: 05/21/19 End: 06/07/19 Due: 06/07/20